Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01442493 · ClinicalTrials.gov registry record · NA
Reengineering Methadone Treatment Study of Patient-centered Methadone Treatment
A NA study of Opiate Dependence, sponsored by Friends Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 2
- Study locations
NCT01442493: Completed NA study of Opiate Dependence, sponsored by Friends Research Institute.
NCT01442493 is a NA study of Opiate Dependence that has completed, run by Friends Research Institute. The registered enrollment target is 300 participants, below the 587-participant average among 15 other Opiate Dependence trials with a reported enrollment target (49% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01442493, a NA study of Opiate Dependence, has completed, sponsored by Friends Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to determine whether a change in the rules and staff roles in methadone treatment programs will result in greater lengths of stay in treatment and lower rates of heroin and cocaine use, crime and HIV-risk behavior as compared to methadone treatment as usual.
Primary Outcome
Number of participants with opiate positive urine tests
Conditions Studied
Interventions
- OTHER Patient-Centered Methadone Treatment
- OTHER Methadone Treatment as usual
Study Locations (2)
Maryland
- Institutes for Behavior Resources REACH - Baltimore
- University of Maryland Drug Treatment Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2011-09 |
| Est. Completion | 2015-08 |
| Phase | NA |
What the finished NCT01442493 record still lists
NCT01442493 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 587-participant average among 15 other Opiate Dependence trials with a reported enrollment target (49% lower).
The record links to 1 condition, with Opiate Dependence appearing as the primary indexed condition, and to 2 interventions - of which Patient-Centered Methadone Treatment is the first listed.
NCT01442493 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01442493 about?
NCT01442493 is a clinical study titled "Reengineering Methadone Treatment Study of Patient-centered Methadone Treatment". The purpose of the study is to determine whether a change in the rules and staff roles in methadone treatment programs will result in greater lengths of stay in treatment and lower rates of heroin and cocaine use, crime and HIV-risk behavior as compared to methadone treatment as usual.
What is the current status of trial NCT01442493?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2011-09. Estimated completion is 2015-08.
What conditions does trial NCT01442493 study?
This clinical trial studies the following conditions: Opiate Dependence.
What interventions are being tested in trial NCT01442493?
The interventions under investigation include: Patient-Centered Methadone Treatment (OTHER), Methadone Treatment as usual (OTHER).
Who is sponsoring clinical trial NCT01442493?
This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01442493 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opiate Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01442493's enrollment target sits among peer trials
300 3rd of 15 higher than 13 of 15 other Opiate Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opiate Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Project Relief: Developing Brain Stimulation as a Treatment for Chronic Pain
COMPLETED · NA
-
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
COMPLETED · NA
-
Neurobehavioral Measurement of Substance Users in Outpatient Treatment Setting
COMPLETED · NA
-
Imaging Synaptic Density in Cocaine and Opiate Addiction In Vivo Using 11UCB-J PET
COMPLETED · NA
-
Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence
COMPLETED · NA
-
Cocaine Withdrawal and Pharmacotherapy Response
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia